ST

Soumya Tomy

Active Director Director DIN 09838202
DIN 09838202 First appointment Dec 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value •••• Premium profile

About Soumya Tomy

Data last updated:

Soumya Tomy is a Director at Asterima Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Asterima Pharmaceuticals Private Limited reported revenue of ₹1.97 Cr (FY 2025).

DIN 09838202
Primary Designation Director
Industry Pharma
First Appointment 13 Dec 2022
Oldest Company Age 10 yrs
Largest company Asterima Pharmaceuticals Private Limited · ₹1.97 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Dec 20222016₹1.97 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Asterima Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Soumya Tomy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Soumya Tomy

Soumya Tomy currently holds 1 directorship: Asterima Pharmaceuticals Private Limited (Director, since 13 Dec 2022, revenue ₹1.97 Cr (FY 2025)).

Soumya Tomy was first appointed on 13 Dec 2022 as Director at Asterima Pharmaceuticals Private Limited.

The current boards of Soumya Tomy's companies include Arun (Asterima Pharmaceuticals Private Limited), Girish (Asterima Pharmaceuticals Private Limited), Mandeep Warrier (Asterima Pharmaceuticals Private Limited), Saneesh Methanath (Asterima Pharmaceuticals Private Limited), Sumesh Methanath (Asterima Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available